Michael Alfieri

Principle Financial Officer, Genocea (United States).

Companies

Aldeyra Therapeutics, Inc.Principal Financial Officer Sep 10, 2024 to now¹
Proteostasis Therapeutics (United States)Interim Head of Finance May 15, 2020 to May 15, 2020²
Genocea (United States)Principle Financial Officer Jun 28, 2018 to Feb 11, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aldeyra Therapeutics, Inc. ALDX7,500 shares⁴$5.7K at $0.76Mar 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 18, 2026Bought 5,000 shares at $1.42 of Aldeyra Therapeutics, Inc.⁴
Aug 13, 2025Bought 2,500 shares at $5.30 of Aldeyra Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAldeyra Therapeutics, Inc., Principal Financial Officer
2
SEC EDGARProteostasis Therapeutics (United States), Interim Head of Finance
3
SEC EDGARGenocea (United States), Principle Financial Officer
4
SEC EDGARAldeyra Therapeutics, Inc. shares after the filing of Mar 18, 2026
5
SEC EDGARForm 4 filed Aug 15, 2025